Notice2024-25906
Healthcare Infection Control Practices Advisory Committee; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 7, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). The meeting is open to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 216 (Thursday, November 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 216 (Thursday, November 7, 2024)]
[Notices]
[Pages 88281-88282]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-25906]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee;
Correction
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces an amendment
to the following meeting of the Healthcare Infection Control Practices
Advisory Committee (HICPAC). The meeting is open to the public.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst,
Division of Healthcare Quality Promotion, National Center for Emerging
and Zoonotic Infectious Diseases, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia
30329-4027. Telephone: (404) 718-8039; Email: <a href="/cdn-cgi/l/email-protection#e9a1a0aab9a8aaa98a8d8ac78e869f"><span class="__cf_email__" data-cfemail="99d1d0dac9d8dad9fafdfab7fef6ef">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Correction
Notice is hereby given of a change in the meeting of the Healthcare
Infection Control Practices Advisory Committee; November 14, 2024, from
9 a.m. to 5 p.m., EST, and November 15, 2024, from 9 a.m. to 12 p.m.,
EST, in the original Federal Register notice.
Notice of the virtual meeting was published in the Federal Register
on October 17, 2024, 89 FR 83688.
The meeting notice is being amended to update the dates section;
addresses section; and supplementary information section, including the
addition of instructions for providing written public comment. These
sections should read as follows:
DATES: The meeting will be held on November 14, 2024, from 8 a.m. to
5:45 p.m., EST, and November 15, 2024, from 8 a.m. to 12:30 p.m., EST.
ADDRESSES: The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the HICPAC website at <a href="https://www.cdc.gov/hicpac/php/upcoming-meeting/index.html">https://www.cdc.gov/hicpac/php/upcoming-meeting/index.html</a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Healthcare Infection Control Practices Advisory
Committee (HICPAC) is charged with providing advice and guidance to the
Director, Division of Healthcare Quality Promotion; the Director,
National Center for Emerging and Zoonotic Infectious Diseases; the
Director, Centers for Disease Control and Prevention (CDC); and the
Secretary, Department of Health and Human Services, regarding (1) the
practice of healthcare infection prevention and control; (2) strategies
for surveillance, prevention, and control of infections, antimicrobial
resistance, and related events in settings where healthcare is
provided; and (3) periodic updating of CDC guidelines and other policy
statements regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda will include the following
updates: the Division of Healthcare Quality Promotion; the Isolation
Precautions Guideline Workgroup; and the Healthcare Personnel Guideline
Workgroup. Agenda items are subject to change as priorities dictate.
Public Participation
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Priority will be given to
individuals who submit a request to make an oral public comment before
the meeting according to the procedures below. All persons interested
in making an oral public comment at the November 14-15, 2024, HICPAC
meeting must submit a request between October 15, 2024, and October 25,
2024, at https://www.cdc.gov/hicpac/php/upcoming-
[[Page 88282]]
meeting/index.html no later than 5 p.m., EDT, on October 25, 2024,
according to the instructions provided. If the number of persons
requesting to speak is greater than can be reasonably accommodated
during the scheduled time, CDC will conduct a random draw to determine
the speakers for the scheduled public comment session. CDC staff will
notify individuals regarding their request to speak by email by
November 1, 2024.
Written Public Comment: Written comments should be submitted by
email to <a href="/cdn-cgi/l/email-protection#377f7e746776747754535419505841"><span class="__cf_email__" data-cfemail="93dbdad0c3d2d0d3f0f7f0bdf4fce5">[email protected]</span></a>. The deadline for receipt of written public
comments is November 22, 2024. All submissions must contain the
submitter's name, address, and organizational affiliation, as well as
the topic being addressed. Written comments should not exceed one
single-spaced typed page in length, not including attachments. All
written comments will be shared with the Committee.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-25906 Filed 11-6-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.